Analyst Ratings for Myriad Genetics (MYGN) [Buys]
MYGN Rating Summary
MYGN Price Target Summary
- Highest: $31.00 (Goldman Sachs)
- Lowest: $17.00 (JPMorgan)
- Average: $23.25
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$23.25 (+8.6%)
* Over Last 12-Mos
Rating Score: 2.9 / 10 Percentile Rank: 24%
Rating Score: 2.9 / 10 Percentile Rank: 24%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
12/14/2023 | Guggenheim | Subbu Nambi | New Coverage | Buy (N/A) |
23.00 (N/A) |
19.05 (21.40) |
12.34% | Details |
12/13/2023 | Wolfe Research | Doug Schenkel | New Coverage | Outperform (N/A) |
N/A (N/A) |
19.05 (21.40) |
12.34% | Details |